Our findings suggest an association between AD pathology and the SIRT2 pathway, astrocyte and microglia activation, and BBB dysfunction, as reflected by concentration changes in the CSF of SIRT2, HGF, MMP10, and CXCL5. The gene discussed is SIRT2; the disease is Alzheimer disease.